Braveheart Bio, Inc. (BRVE)Healthcare | Biotechnology | San Francisco, United States | NasdaqGM
19.34 USD
+0.01
(0.052%)
⇧
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 19.34 |
Hot Take ↕ | Oct. 10, 2026, 7:39 a.m. EDT
The immediate outlook is severely clouded by a brutal technical breakdown. Despite a 'strong buy' analyst consensus, the stock has lost nearly 22% over the last two months, trading well below both its 50-day and 200-day averages, while volume remains depressed relative to the average. This suggests a lack of institutional interest and a failure to find a floor despite the optimistic guidance. Looking further ahead, the investment case collapses entirely due to deteriorating fundamentals. The company reports negative earnings per share, negative operating cash flow, and a negative book value, indicating that shareholders have lost more than their initial investment on a liquidation basis. With no recent dividends to provide income and a complete absence of price history to suggest a turnaround, the security presents a classic value trap where the market has correctly priced out the business risks. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.489 |
| Market Cap | 1,741,353,600 |
| Forward P/E | -9.72 |
| Website | https://www.braveheart.bio |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.35134226 |
| Address1 | One Letterman Drive |
| Address2 | Building A Suite A4-300 |
| All Time High | 32.0 |
| All Time Low | 17.86 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 492,750 |
| Average Daily Volume3 Month | 536,450 |
| Average Volume | 536,450 |
| Average Volume10Days | 492,750 |
| Book Value | -12.726 |
| City | San Francisco |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 19.34 |
| Current Ratio | 13.628 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 19.9 |
| Day Low | 18.6249 |
| Debt To Equity | 0.489 |
| Display Name | Braveheart Bio |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 1,670,007,936 |
| Eps Forward | -1.99 |
| Eps Trailing Twelve Months | -6.08 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 25.1875 |
| Fifty Day Average Change | -5.8475 |
| Fifty Day Average Change Percent | -0.23215881 |
| Fifty Two Week Change Percent | -35.134228 |
| Fifty Two Week High | 32.0 |
| Fifty Two Week High Change | -12.66 |
| Fifty Two Week High Change Percent | -0.395625 |
| Fifty Two Week Low | 17.86 |
| Fifty Two Week Low Change | 1.4799995 |
| Fifty Two Week Low Change Percent | 0.08286671 |
| Fifty Two Week Range | 17.86 - 32.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,786,023,000,000 |
| Float Shares | 12,721,378 |
| Forward Eps | -1.99 |
| Forward P E | -9.718593 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 49 |
| Fullday Change | 0.010000229 |
| Fullday Change Percent | 0.051734243 |
| Fullday Price | 19.34 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.58158 |
| Held Percent Institutions | 0.24293 |
| Implied Shares Outstanding | 90,038,969 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-08-06 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. It develops and offers BHB-1893 and HRS-1893, an oral small-molecule cardiac myosin inhibitor (CMI) for the treatment of obstructive HCM and non-obstructive HCM. The company was incorporated in 2024 and is headquartered in San Francisco, California. |
| Long Name | Braveheart Bio, Inc. |
| Market | us_market |
| Market Cap | 1,741,353,600 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_1959705903 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -98,455,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,927,734,326 |
| Number Of Analyst Opinions | 4 |
| Open | 19.33 |
| Operating Cashflow | -24,150,000 |
| Operating Margins | 0.0 |
| Phone | 415 707 6312 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 19.34 |
| Post Market Time | 1,792,008,015 |
| Previous Close | 19.33 |
| Price Hint | 2 |
| Price To Book | -1.5197234 |
| Profit Margins | 0.0 |
| Quick Ratio | 13.56 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.010000229 |
| Regular Market Change Percent | 0.051734243 |
| Regular Market Day High | 19.9 |
| Regular Market Day Low | 18.6249 |
| Regular Market Day Range | 18.6249 - 19.9 |
| Regular Market Open | 19.33 |
| Regular Market Previous Close | 19.33 |
| Regular Market Price | 19.34 |
| Regular Market Time | 1,792,008,001 |
| Regular Market Volume | 462,845 |
| Sand P52 Week Change | 0.17004645 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 90,038,969 |
| Shares Percent Shares Out | 0.045900002 |
| Shares Short | 4,128,974 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,397,189 |
| Short Name | Braveheart Bio, Inc. |
| Short Ratio | 6.92 |
| Source Interval | 15 |
| State | CA |
| Symbol | BRVE |
| Target High Price | 48.0 |
| Target Low Price | 40.0 |
| Target Mean Price | 45.25 |
| Target Median Price | 46.5 |
| Total Cash | 122,831,000 |
| Total Cash Per Share | 1.505 |
| Total Debt | 575,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -6.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 25.1875 |
| Two Hundred Day Average Change | -5.8475 |
| Two Hundred Day Average Change Percent | -0.23215881 |
| Type Disp | Equity |
| Volume | 462,845 |
| Website | https://www.braveheart.bio |
| Zip | 94,129 |